Skip to content

Assess the Blood-Oxygen-Level-Dependent (BOLD) Signal Changes in the Brain by Paracetamol as Measured by Functional Magnetic Resonance Imaging (fMRI) in Subjects With Osteoarthritis (OA)

A Randomised, Double-blind, Evaluation of the Effects of Paracetamol on the BOLD fMRI Response to Painful Stimuli in Subjects With Osteoarthritis

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01105936
Enrollment
31
Registered
2010-04-19
Start date
2010-09-01
Completion date
2011-08-01
Last updated
2017-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis, Knee

Keywords

osteoarthritis, pain, paracetamol, Blood-Oxygen-Level-Dependent functional magnetic resonance imaging

Brief summary

Blood-Oxygen-Level-Dependent (BOLD) responses to painful mechanical stimulation of the OA knee following treatment with four consecutive doses (at 8 hour intervals) on giving sustained released paracetamol treatment or placebo will be compared. The fMRI and pain assessments will occur approximately 2-5 hours after taking the final dose.

Detailed description

The objective of this study is to investigate if functional magnetic response imaging (fMRI) can detect the effects of a known pain medicine at over-the-counter doses in people with osteoarthritis (OA) of the knee. The fMRI is a harmless and painless technique that is used in the current study to collect images of brain activity to see if is changed when feeling pain. In this study, BOLD response to mechanical stimulation via pressure stimuli applied to the tibio-femoral joint and patello-femoral in participants with knee OA following four treatment doses of any of three treatment will be compared.

Interventions

DRUGParacetamol

665 mg sustained release paracetamol caplets

DRUGPlacebo

Placebo caplets

Sponsors

GlaxoSmithKline
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of osteoarthritis of at least one knee for 3 months * Male or female at least 45 years of age * Score a minimum of 4 out of 10 on the numerical pain rating and a maximum of 8 at screening

Exclusion criteria

* If female, is pregnant, lactating, or breast feeding * Has secondary cause of knee arthritis * Lower extremity surgery in the last 6 months * Prior injury in the last twelve months to the index knee * Used any analgesics (NSAIDs, COX2 inhibitor, etc) within 5 half lives of study start * Recently used oral or injected glucocorticoids

Design outcomes

Primary

MeasureTime frameDescription
Blood Oxygen Level-Dependent (BOLD) Response in the Tibio-femoral Joint of Knee Osteoarthritis (OA): [BOLD (T-f)]Baseline to 2-5 hours post last dose administrationBOLD response to painful pressure stimuli was evaluated using fMRI. Voxel-wise BOLD scores were reported on a Z-scale (Gaussian,mean=0,SD=1); range -3 (worst score, lowest connectivity) to +3 (best score, highest connectivity). The software derived scores compared the intensity reading in the region to a template, specifically the Montreal Neurological Institute (MNI) Echo-Planar Image (EPI) template. The template provides, for each region, expected (mean/median) intensity for that region, along with expected variation. The BOLD score on the Z-scale represents how far the actual measured intensity is from the expected in the template. A score of 0 would correspond to the mean/median, a score of 1.65 would represent the 90-percentile, -1.65 the 10-percentile, and so on, according to a standard normal distribution.

Secondary

MeasureTime frameDescription
Subjective Numerical Rating Scale (NRS) Response for Treatment Effect on OA Knee Before Stimulation: [NRS (TRT)]Baseline and post-dose before stimulusSubjective NRS response for each participant was calculated as difference of pre-treatment NRS pain assessment before stimulus and post-treatment NRS pain assessment before stimulus. NRS responses was based on an 11 scale rating (0-10), with 0 corresponding to No Pain and 10 corresponding to Extreme Pain or Pain as bad as you can imagine.
Subjective NRS Response for Treatment Effect on Tibio-femoral Stimulation Prior the fMRI Scan: [NRS (T-f Pre-scan)]Baseline and post-dose pre-scan after stimulusSubjective NRS response was calculated for each participant as difference of pre-treatment pain assessment after stimulus and post-treatment pre-scan pain assessment after stimulus on tibio-femoral joint. NRS responses was based on an 11 scale rating (0-10), with 0 corresponding to No Pain and 10 corresponding to Extreme Pain or Pain as bad as you can imagine.
BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]Baseline to 2-5 hours post last dose administrationBOLD response to painful pressure stimuli was evaluated using fMRI. Voxel-wise BOLD scores were reported on a Z-scale (Gaussian,mean=0,SD=1); range -3 (worst score, lowest connectivity) to +3 (best score, highest connectivity). The software derived scores compared the intensity reading in the region to a template, specifically the Montreal Neurological Institute (MNI) Echo-Planar Image (EPI) template. The template provides, for each region, expected (mean/median) intensity for that region, along with expected variation. The BOLD score on the Z-scale represents how far the actual measured intensity is from the expected in the template. A score of 0 would correspond to the mean/median, a score of 1.65 would represent the 90-percentile, -1.65 the 10-percentile, and so on, according to a standard normal distribution
Subjective NRS Response for Treatment Effect on Tibio-femoral Stimulation After the fMRI Scan: [NRS (T-f Post-scan)]Baseline and post-dose post-scan after stimulusSubjective NRS response for treatment effect on tibio-femoral stimulus after the fMRI scan was calculated for each participant as difference of pre-treatment pain assessment after stimulus and post-treatment post-scan pain assessment after stimulus on tibio-femoral. NRS responses was based on an 11 scale rating (0-10), with 0 corresponding to No Pain and 10 corresponding to Extreme Pain or Pain as bad as you can imagine.
Subjective NRS Response for Treatment Effect on Patello-femoral Stimulation After the fMRI Scan: [NRS (P-f Post-scan)]Baseline and post-dose post-scan after stimulusSubjective NRS response for each participant for treatment effect on tibio-femoral stimulus after the fMRI scan was calculated as difference of pre-treatment pain assessment after stimulus and post-treatment post-scan pain assessment after stimulus on patello-femoral. NRS responses was based on an 11 scale rating (0-10), with 0 corresponding to No Pain and 10 corresponding to Extreme Pain or Pain as bad as you can imagine.
Subjective NRS Response for Treatment Effect on Patello-femoral Stimulation Prior the fMRI Scan: [NRS (P-f Pre-scan)]Baseline and post-dose pre-scan after stimulusSubjective NRS response was calculated for each participant as difference of pre-treatment pain assessment after stimulus and post-treatment pre-scan pain assessment after stimulus on patello-femoral. NRS responses was based on an 11 scale rating (0-10), with 0 corresponding to No Pain and 10 corresponding to Extreme Pain or Pain as bad as you can imagine.

Countries

Spain

Participant flow

Recruitment details

Study was conducted at a single centre in Spain.

Pre-assignment details

Out of 33 screened participants, 31 were randomized, while 2 participants were considered as screen failures

Participants by arm

ArmCount
Total Participants for Baseline Measurement
All randomized participants except one were evaluated for baseline measures. One participant had misallocated treatments that could not be determined. Therefore, this participant was excluded from all populations including safety.
30
Total30

Withdrawals & dropouts

PeriodReasonFG000FG001FG002FG003
Period 1Adverse Event0001
Period 2Adverse Event1000
Period 3Protocol Violation0200

Baseline characteristics

CharacteristicTotal Participants for Baseline Measurement
Age, Customized
Years
68.5 Years
STANDARD_DEVIATION 7.97
Sex: Female, Male
Female
26 Participants
Sex: Female, Male
Male
4 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
— / —— / —— / —
other
Total, other adverse events
3 / 293 / 282 / 30
serious
Total, serious adverse events
0 / 290 / 280 / 30

Outcome results

Primary

Blood Oxygen Level-Dependent (BOLD) Response in the Tibio-femoral Joint of Knee Osteoarthritis (OA): [BOLD (T-f)]

BOLD response to painful pressure stimuli was evaluated using fMRI. Voxel-wise BOLD scores were reported on a Z-scale (Gaussian,mean=0,SD=1); range -3 (worst score, lowest connectivity) to +3 (best score, highest connectivity). The software derived scores compared the intensity reading in the region to a template, specifically the Montreal Neurological Institute (MNI) Echo-Planar Image (EPI) template. The template provides, for each region, expected (mean/median) intensity for that region, along with expected variation. The BOLD score on the Z-scale represents how far the actual measured intensity is from the expected in the template. A score of 0 would correspond to the mean/median, a score of 1.65 would represent the 90-percentile, -1.65 the 10-percentile, and so on, according to a standard normal distribution.

Time frame: Baseline to 2-5 hours post last dose administration

Population: Intention-to-treat (ITT) population: all participants per period who received at least one treatment and had at least one post-baseline efficacy assessment. Missing data was not imputed.

ArmMeasureValue (MEAN)
Paracetamol 665 mgBlood Oxygen Level-Dependent (BOLD) Response in the Tibio-femoral Joint of Knee Osteoarthritis (OA): [BOLD (T-f)]NA Z-score
PlaceboBlood Oxygen Level-Dependent (BOLD) Response in the Tibio-femoral Joint of Knee Osteoarthritis (OA): [BOLD (T-f)]NA Z-score
No TreatmentBlood Oxygen Level-Dependent (BOLD) Response in the Tibio-femoral Joint of Knee Osteoarthritis (OA): [BOLD (T-f)]NA Z-score
Secondary

BOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]

BOLD response to painful pressure stimuli was evaluated using fMRI. Voxel-wise BOLD scores were reported on a Z-scale (Gaussian,mean=0,SD=1); range -3 (worst score, lowest connectivity) to +3 (best score, highest connectivity). The software derived scores compared the intensity reading in the region to a template, specifically the Montreal Neurological Institute (MNI) Echo-Planar Image (EPI) template. The template provides, for each region, expected (mean/median) intensity for that region, along with expected variation. The BOLD score on the Z-scale represents how far the actual measured intensity is from the expected in the template. A score of 0 would correspond to the mean/median, a score of 1.65 would represent the 90-percentile, -1.65 the 10-percentile, and so on, according to a standard normal distribution

Time frame: Baseline to 2-5 hours post last dose administration

Population: ITT population: all participants per period who received at least one treatment and had at least one post-baseline efficacy assessment. Missing data was not imputed.

ArmMeasureGroupValue (MEAN)Dispersion
Paracetamol 665 mgBOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]BOLD - Frontal CortexNA Z-score
Paracetamol 665 mgBOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]BOLD - Sensory Cortex (a)0.16 Z-scoreStandard Deviation 0.36
Paracetamol 665 mgBOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]BOLD - Supramarginal Gyrus0.46 Z-scoreStandard Deviation 0.48
Paracetamol 665 mgBOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]BOLD - Thalamus0.48 Z-scoreStandard Deviation 1.34
Paracetamol 665 mgBOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]BOLD - Subgenu PrefrontalNA Z-score
Paracetamol 665 mgBOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]BOLD - InsulaNA Z-score
Paracetamol 665 mgBOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]BOLD - Sensory Cortex (b)NA Z-score
PlaceboBOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]BOLD - Subgenu Prefrontal-0.27 Z-scoreStandard Deviation 0.41
PlaceboBOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]BOLD - Sensory Cortex (b)-0.11 Z-scoreStandard Deviation 0.6
PlaceboBOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]BOLD - Sensory Cortex (a)NA Z-score
PlaceboBOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]BOLD - Thalamus-0.68 Z-scoreStandard Deviation 1.74
PlaceboBOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]BOLD - Insula0.12 Z-scoreStandard Deviation 0.51
PlaceboBOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]BOLD - Supramarginal GyrusNA Z-score
PlaceboBOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]BOLD - Frontal Cortex-0.04 Z-scoreStandard Deviation 0.31
No TreatmentBOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]BOLD - Supramarginal Gyrus0.76 Z-scoreStandard Deviation 0.49
No TreatmentBOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]BOLD - ThalamusNA Z-score
No TreatmentBOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]BOLD - Sensory Cortex (b)0.44 Z-scoreStandard Deviation 0.48
No TreatmentBOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]BOLD - Subgenu Prefrontal0.19 Z-scoreStandard Deviation 0.37
No TreatmentBOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]BOLD - Frontal Cortex0.26 Z-scoreStandard Deviation 0.42
No TreatmentBOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]BOLD - Sensory Cortex (a)0.48 Z-scoreStandard Deviation 0.48
No TreatmentBOLD Response in the Patello-femoral Joint of Knee Osteoarthritis: [BOLD (P-f)]BOLD - Insula0.62 Z-scoreStandard Deviation 0.62
Secondary

Subjective NRS Response for Treatment Effect on Patello-femoral Stimulation After the fMRI Scan: [NRS (P-f Post-scan)]

Subjective NRS response for each participant for treatment effect on tibio-femoral stimulus after the fMRI scan was calculated as difference of pre-treatment pain assessment after stimulus and post-treatment post-scan pain assessment after stimulus on patello-femoral. NRS responses was based on an 11 scale rating (0-10), with 0 corresponding to No Pain and 10 corresponding to Extreme Pain or Pain as bad as you can imagine.

Time frame: Baseline and post-dose post-scan after stimulus

Population: ITT population: all participants per period who received at least one treatment and had at least one post-baseline efficacy assessment. Missing data was not imputed.

ArmMeasureValue (MEAN)Dispersion
Paracetamol 665 mgSubjective NRS Response for Treatment Effect on Patello-femoral Stimulation After the fMRI Scan: [NRS (P-f Post-scan)]0.30 Score on a ScaleStandard Deviation 1.66
PlaceboSubjective NRS Response for Treatment Effect on Patello-femoral Stimulation After the fMRI Scan: [NRS (P-f Post-scan)]-0.48 Score on a ScaleStandard Deviation 1.62
No TreatmentSubjective NRS Response for Treatment Effect on Patello-femoral Stimulation After the fMRI Scan: [NRS (P-f Post-scan)]-0.39 Score on a ScaleStandard Deviation 1.92
Secondary

Subjective NRS Response for Treatment Effect on Patello-femoral Stimulation Prior the fMRI Scan: [NRS (P-f Pre-scan)]

Subjective NRS response was calculated for each participant as difference of pre-treatment pain assessment after stimulus and post-treatment pre-scan pain assessment after stimulus on patello-femoral. NRS responses was based on an 11 scale rating (0-10), with 0 corresponding to No Pain and 10 corresponding to Extreme Pain or Pain as bad as you can imagine.

Time frame: Baseline and post-dose pre-scan after stimulus

Population: ITT population: all participants per period who received at least one treatment and had at least one post-baseline efficacy assessment. Missing data was not imputed.

ArmMeasureValue (MEAN)Dispersion
Paracetamol 665 mgSubjective NRS Response for Treatment Effect on Patello-femoral Stimulation Prior the fMRI Scan: [NRS (P-f Pre-scan)]0.60 Score on a ScaleStandard Deviation 1.23
PlaceboSubjective NRS Response for Treatment Effect on Patello-femoral Stimulation Prior the fMRI Scan: [NRS (P-f Pre-scan)]0.43 Score on a ScaleStandard Deviation 0.95
No TreatmentSubjective NRS Response for Treatment Effect on Patello-femoral Stimulation Prior the fMRI Scan: [NRS (P-f Pre-scan)]0.00 Score on a ScaleStandard Deviation 0.91
Secondary

Subjective NRS Response for Treatment Effect on Tibio-femoral Stimulation After the fMRI Scan: [NRS (T-f Post-scan)]

Subjective NRS response for treatment effect on tibio-femoral stimulus after the fMRI scan was calculated for each participant as difference of pre-treatment pain assessment after stimulus and post-treatment post-scan pain assessment after stimulus on tibio-femoral. NRS responses was based on an 11 scale rating (0-10), with 0 corresponding to No Pain and 10 corresponding to Extreme Pain or Pain as bad as you can imagine.

Time frame: Baseline and post-dose post-scan after stimulus

Population: ITT population: all participants per period who received at least one treatment and had at least one post-baseline efficacy assessment. Missing data was not imputed.

ArmMeasureValue (MEAN)Dispersion
Paracetamol 665 mgSubjective NRS Response for Treatment Effect on Tibio-femoral Stimulation After the fMRI Scan: [NRS (T-f Post-scan)]0.15 Score on a ScaleStandard Deviation 1.18
PlaceboSubjective NRS Response for Treatment Effect on Tibio-femoral Stimulation After the fMRI Scan: [NRS (T-f Post-scan)]0.09 Score on a ScaleStandard Deviation 1.38
No TreatmentSubjective NRS Response for Treatment Effect on Tibio-femoral Stimulation After the fMRI Scan: [NRS (T-f Post-scan)]-0.13 Score on a ScaleStandard Deviation 1.1
Secondary

Subjective NRS Response for Treatment Effect on Tibio-femoral Stimulation Prior the fMRI Scan: [NRS (T-f Pre-scan)]

Subjective NRS response was calculated for each participant as difference of pre-treatment pain assessment after stimulus and post-treatment pre-scan pain assessment after stimulus on tibio-femoral joint. NRS responses was based on an 11 scale rating (0-10), with 0 corresponding to No Pain and 10 corresponding to Extreme Pain or Pain as bad as you can imagine.

Time frame: Baseline and post-dose pre-scan after stimulus

Population: ITT population: all participants per period who received at least one treatment and had at least one post-baseline efficacy assessment. Missing data was not imputed.

ArmMeasureValue (MEAN)Dispersion
Paracetamol 665 mgSubjective NRS Response for Treatment Effect on Tibio-femoral Stimulation Prior the fMRI Scan: [NRS (T-f Pre-scan)]0.55 Score on a ScaleStandard Deviation 0.89
PlaceboSubjective NRS Response for Treatment Effect on Tibio-femoral Stimulation Prior the fMRI Scan: [NRS (T-f Pre-scan)]0.17 Score on a ScaleStandard Deviation 1.07
No TreatmentSubjective NRS Response for Treatment Effect on Tibio-femoral Stimulation Prior the fMRI Scan: [NRS (T-f Pre-scan)]0.00 Score on a ScaleStandard Deviation 0.74
Secondary

Subjective Numerical Rating Scale (NRS) Response for Treatment Effect on OA Knee Before Stimulation: [NRS (TRT)]

Subjective NRS response for each participant was calculated as difference of pre-treatment NRS pain assessment before stimulus and post-treatment NRS pain assessment before stimulus. NRS responses was based on an 11 scale rating (0-10), with 0 corresponding to No Pain and 10 corresponding to Extreme Pain or Pain as bad as you can imagine.

Time frame: Baseline and post-dose before stimulus

Population: ITT population: all participants per period who received at least one treatment and had at least one post-baseline efficacy assessment. Missing data was not imputed.

ArmMeasureValue (MEAN)Dispersion
Paracetamol 665 mgSubjective Numerical Rating Scale (NRS) Response for Treatment Effect on OA Knee Before Stimulation: [NRS (TRT)]0.95 Score on a ScaleStandard Deviation 1.67
PlaceboSubjective Numerical Rating Scale (NRS) Response for Treatment Effect on OA Knee Before Stimulation: [NRS (TRT)]-0.52 Score on a ScaleStandard Deviation 1.53
No TreatmentSubjective Numerical Rating Scale (NRS) Response for Treatment Effect on OA Knee Before Stimulation: [NRS (TRT)]0.48 Score on a ScaleStandard Deviation 1.83

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026